XCHA:F:F-Xtrackers - CSI300 Swap UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 13.018

Change

-0.05 (-0.40)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-24 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SXR8:F iShares Core S&P 500 UCITS ETF..

N/A

USD 101.74B
UIM5:F UBS (Lux) Fund Solutions - MSC..

+0.19 (+0.39%)

USD 101.37B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

+0.21 (+0.40%)

USD 96.03B
XDNY:F Xtrackers MSCI Japan ESG Scree..

N/A

USD 57.02B
XJSE:F Xtrackers II - Japan Governmen..

-0.01 (-0.13%)

USD 53.72B
VUSA:F Vanguard Funds Public Limited ..

+3.76 (+4.30%)

USD 51.63B
SXRZ:F iShares VII PLC - iShares Nikk..

+0.70 (+0.32%)

USD 45.80B
0ZC:F Zscaler Inc

-0.78 (-0.44%)

USD 37.92B
BSND:F Danone SA

+0.10 (+0.70%)

USD 33.83B
VGWL:F Vanguard FTSE All-World UCITS ..

+3.70 (+3.23%)

USD 24.77B

ETFs Containing XCHA:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -11.13% 24% F 43% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -11.13% 24% F 42% F
Trailing 12 Months  
Capital Gain 6.69% 77% C+ 67% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 6.69% 74% C 59% D-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 6.42% 57% F 57% F
Dividend Return 6.42% 54% F 49% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 9.72% 69% C- 92% A
Risk Adjusted Return 66.11% 66% D+ 75% C
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike